Login
$VNRX
$0.19 -$0.01 (2.8%) After hours

$VNRX 8-K/A SEC Filings

Filed On Filing
13 Nov 2025 8-K/A: Entry into a Material Definitive Agreement

As previously reported, on October 10, 2025, the Company entered into an Underwriting Agreement (the “Underwriting Agreement”) with Newbridge Securities Corporation (the “Underwriter”), relating to an underwritten public offering of 11,5...

10 Nov 2025 8-K/A: Entry into a Material Definitive Agreement

As previously reported, on October 10, 2025, the Company entered into an Underwriting Agreement (the “Underwriting Agreement”) with Newbridge Securities Corporation (the “Underwriter”), relating to an underwritten public offering of 11,5...

11 Jun 2012 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more

On September 26, 2011, the Company, then under the name Standard Capital Corporation, and its controlling stockholders (the “Controlling Stockholders”) entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Singapo...

08 May 2012 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more

ValiRx PLC (incorporated and registered in England and Wales under company number 3916791 the registered office of which is at 24 Greville Street, London EC1N 8SS (the "Seller"); and

05 Apr 2012 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more

We have audited the accompanying balance sheet of Singapore Volition Pte. Ltd.. as of December 31, 2010, and the related statements of operations, stockholders’ equity (deficit) and cash flows from inception on August 5, 2010 through Dec...

24 Feb 2012 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more

Vice-President and Minister of Sustainable Development and Public Service

11 Jan 2012 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more

ValiRx PLC (incorporated and registered in England and Wales under company number 3916791 the registered office of which is at 24 Greville Street, London EC1N 8SS (the "Seller"); and

01 Nov 2011 8-K/A: Financial Statements and Exhibits

(The accompanying notes are an integral part of these financial statements)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support